Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells

Autor: Mariapia Degli-Esposti, Davis-Smith T, Ws, Din, Pj, Smolak, Rg, Goodwin, Ca, Smith

Publikováno v: Europe PubMed Central

The lymphotoxin beta receptor (LT beta R) was originally described as a transcribed sequence encoded on human chromosome 12p, with homology to the TNF receptor family. Subsequently, a recombinant LT beta R was shown to bind LT alpha LT beta heteromer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::02d4365b1f239069e523e771ddf467a3
https://pubmed.ncbi.nlm.nih.gov/9029113

Epidermolysis bullosa acquisita: a case series of three paediatric patients.

Autor: Bageta ML; Department of Dermatology, Great Ormond Street Hospital NHS Foundation Trust, London, UK., Cella E; Department of Dermatology, Hospital Nacional de Pediatria Prof. Dr Juan P. Garrahan', Buenos Aires, Argentina., Cervini AB; Department of Dermatology, Hospital Nacional de Pediatria Prof. Dr Juan P. Garrahan', Buenos Aires, Argentina., Centeno MDV; Histopathology, Hospital Nacional de Pediatria 'Prof. Dr. Juan P. Garrahan' Buenos Aires, Buenos Aires, Argentina., Roquel L; Department of Biochemistry, Clinical Analysis Laboratory Roquel, Buenos Aires, Argentina., Mee JB; Immunodermatology Laboratory, Viapath Analytics LLP, St Thomas' Hospital, London, UK., Groves RW; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Calonje E; Department of Dermatopathology, St John's Institute of Dermatology, King's College London, London, UK., Goodwin RG; Department of Dermatology, St Woolos Hospital, Newport, UK., Mellerio JE; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Petrof G; Department of Dermatology, Great Ormond Street Hospital NHS Foundation Trust, London, UK., Martinez AE; Department of Dermatology, Great Ormond Street Hospital NHS Foundation Trust, London, UK.

Publikováno v: Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Jul; Vol. 47 (7), pp. 1346-1349. Date of Electronic Publication: 2022 Mar 22.

Evaluating paediatric dermatology telephone clinics during COVID-19 from a dual clinician and patient perspective: a prospective study.

Autor: Lowe A; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK., Dawood S; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK., Al-Tayeb A; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK., Hancock P; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK., Pararajasingam A; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK., Ali F; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK., Goodwin RG; Department of Dermatology, Royal Gwent Hospital, Newport, Gwent, Wales, UK.

Publikováno v: Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 553-560. Date of Electronic Publication: 2021 Nov 22.

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.

Autor: Dand N; School of Basic & Medical Biosciences, London, United Kingdom., Duckworth M; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Baudry D; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Russell A; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Curtis CJ; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom; Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Lee SH; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, United Kingdom; Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Evans I; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Mason KJ; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Alsharqi A; Royal Liverpool and Brodgreen University Hospital Trusts, Liverpool, United Kingdom., Becher G; Alan Lyell Centre for Dermatology, West Glasgow ACH, Glasgow, United Kingdom., Burden AD; Institute of Infection, Inflammation and Immunity, University of Glasgow, Glasgow, United Kingdom., Goodwin RG; Aneurin Bevan University Health Board, Gwent, United Kingdom., McKenna K; Department of Dermatology, Belfast City Hospital, Belfast, United Kingdom., Murphy R; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom; Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Perera GK; Chelsea & Westminster Hospital NHS Foundation Trust, West Middlesex University Hospital, London, United Kingdom., Rotarescu R; University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom., Wahie S; University Hospital North Durham, Durham, United Kingdom., Wright A; Centre for Skin Science, University of Bradford, Bradford, United Kingdom; Dermatology Department, St Luke's Hospital, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom., Reynolds NJ; Dermatological Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, United Kingdom; Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom; Newcastle MRC/EPSRC Molecular Pathology Node, Newcastle University, Newcastle upon Tyne, United Kingdom., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Griffiths CEM; Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, United Kingdom., Smith CH; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom., Simpson MA; School of Basic & Medical Biosciences, London, United Kingdom. Electronic address: michael.simpson@kcl.ac.uk., Barker JN; St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, London, United Kingdom. Electronic address: jonathan.barker@kcl.ac.uk.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2019 Jun; Vol. 143 (6), pp. 2120-2130. Date of Electronic Publication: 2018 Dec 20.

Allergic contact dermatitis to peppermint foot spray.

Autor: Kalavala M; Department of Occupational Dermatology, Royal Gwent Hospital, Newport, UK. manjuk04@yahoo.com, Hughes TM, Goodwin RG, Anstey AV, Stone NM

Publikováno v: Contact dermatitis [Contact Dermatitis] 2007 Jul; Vol. 57 (1), pp. 57-8.